As of 2025-11-18, the EV/EBITDA ratio of Amryt Pharma Holdings Ltd (AMYT.L) is -27.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AMYT.L's latest enterprise value is 512.51 mil GBP. AMYT.L's TTM EBITDA according to its financial statements is -18.55 mil GBP. Dividing these 2 quantities gives us the above AMYT.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.8x - 5.9x | 4.4x |
| Forward P/E multiples | 4.5x - 5.9x | 5.2x |
| Fair Price | (39.15) - (45.29) | (40.30) |
| Upside | -127.4% - -131.7% | -128.2% |
| Date | EV/EBITDA |